Literature DB >> 17121315

Focus on juvenile idiopathic arthritis according to the 2001 Edmonton revised classification from the International League of Associations for Rheumatology: an Italian experience.

A Stabile1, L Avallone, A Compagnone, V Ansuini, B Bertoni, D Rigante.   

Abstract

OBJECTIVE: To classify a cohort of Italian patients categorized as affected with juvenile idiopathic arthritis (JIA) according to the revised 2001 Edmonton International League of Associations for Rheumatology (ILAR) criteria.
METHODS: Eighty-five patients with JIA firstly framed depending on traditional criteria during the last ten years were reallocated according to the JIA revised criteria proposed in 2001 by ILAR in Edmonton.
RESULTS: The revision consented to define the following distribution of patients: 28.2% systemic, 55.3% oligoarticular and 11.8% polyarticular forms; only one child was defined as having psoriatic arthritis, one child with enthesitis-associated arthritis and two with the undifferentiated form of JIA. DISCUSSION: The 97.6% of the recruited patients were strictly classified according to the Edmonton ILAR criteria, demonstrating a very low number of patients whose arthritis could not be assigned to any JIA category due to unfulfillment of the required criteria.

Entities:  

Mesh:

Year:  2006        PMID: 17121315

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Post-inflammatory retinal dystrophy in CINCA syndrome.

Authors:  Donato Rigante; Achille Stabile; Angelo Minnella; Laura Avallone; Lucia Ziccardi; Giulia Bersani; Giovanna Stifano; Adele Compagnone; Benedetto Falsini
Journal:  Rheumatol Int       Date:  2009-05-08       Impact factor: 2.631

2.  Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome.

Authors:  Donato Rigante; Piero Valentini; Roberta Onesimo; Donatella Francesca Angelone; Alessia De Nisco; Giulia Bersani; Angelica Bibiana Delogu
Journal:  Rheumatol Int       Date:  2009-05-20       Impact factor: 2.631

3.  Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.

Authors:  R Sighart; J Rech; A Hueber; N Blank; S Löhr; A Reis; H Sticht; U Hüffmeier
Journal:  Rheumatol Int       Date:  2017-11-20       Impact factor: 2.631

Review 4.  Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.

Authors:  Michael W Beresford
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

5.  Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.

Authors:  Tadamori Takahara; Masaki Shimizu; Yasuo Nakagishi; Noriko Kinjo; Akihiro Yachie
Journal:  Rheumatol Int       Date:  2014-06-12       Impact factor: 2.631

Review 6.  The Etiology of Juvenile Idiopathic Arthritis.

Authors:  Donato Rigante; Annalisa Bosco; Susanna Esposito
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 10.817

7.  A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.

Authors:  Takanori Noto; Hiroki Seto; Junji Fukuhara; Masao Murabayashi; Akihiro Yachie; Mamoru Ayusawa; Ichiro Morioka
Journal:  BMC Pediatr       Date:  2018-12-12       Impact factor: 2.125

8.  Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis.

Authors:  Sharad Dev; Anup Singh
Journal:  J Family Med Prim Care       Date:  2019-06

9.  A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis.

Authors:  Rubén Burgos-Vargas; Shirley M L Tse; Gerd Horneff; Aileen L Pangan; Jasmina Kalabic; Sandra Goss; Kristina Unnebrink; Jaclyn K Anderson
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11       Impact factor: 4.794

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.